BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 4, 2018
View Archived Issues
FDA grants orphan drug designation to GBC-0905 for the treatment FSHD
Read More
vTv Therapeutics licenses PDE4 inhibitor program to Newsoara Biopharma
Read More
Tegsedi receives positive opinion in Europe
Read More
Kyowa Hakko Kirin initiated phase III trial of bardoxolone methyl for diabetic kidney disease
Read More
Bardoxolone methyl receives orphan drug designation in Europe for the treatment of Alport syndrome
Read More
Circassia submits NDA for Duaklir and sNDA for Tudorza to the FDA
Read More
Celsius Therapeutics gains rights to Harbour Antibodies' antibody discovery platform
Read More
Rxulti receives positive opinion in Europe for the treatment of schizophrenia in adults
Read More
Exondys receives negative CHMP opinion
Read More
First clinical data for the IDH1/2 inhibitor AG-881 in solid tumors
Read More
Aimovig receives positive CHMP opinion for the prevention of migraine
Read More
Neural stem cells delivering chimeric orthopoxvirus created to treat ovarian cancer
Read More
Kyushu University patents EGFR inhibitors
Read More
Bruton tyrosine kinase inhibitors divulged by Daewoong Pharmaceutical
Read More
Vanderbilt University synthesizes new mGlu4 receptor positive allosteric modulators
Read More
Fully human antibody cocktail shows postexposure protection against lethal Ebola virus in primates
Read More
U.S. orphan designation granted to Alnylam Pharmaceuticals siRNA therapy for amyloidosis
Read More
FDA approves Olumiant 2 mg for moderate to severe rheumatoid arthritis
Read More
Taiwan Liposome submits IND for phase I/II trial of TLC-178 in pediatric rhabdomyosarcoma
Read More
EMA CHMP recommends approval of Sandoz adalimumab biosimilar
Read More
FDA approves Consensi for osteoarthritis pain and hypertension
Read More
Novartis completes divestment of joint venture to GSK
Read More
First phase I data presented for LOXO-292 in RET-altered cancers
Read More
EMA committee recommends approval of Translarna for younger children with DMD
Read More
EMA committee backs approval of trastuzumab biosimilar Trazimera
Read More
